RecruitingNCT06128343

Anatomical-Clinical Base of Adenocarcinoma Pancreatic


Sponsor

University Hospital, Toulouse

Enrollment

1,500 participants

Start Date

Nov 16, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

BACAP-2 is a prospective biobank dedicated to the pancreatic adenocarcinoma including clinical data and biological samples from tumor. The aim is to enrich the previous propective collection BACAP in order to support future research projects.


Eligibility

Min Age: 18 YearsMax Age: 120 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting detailed clinical and anatomical data on patients who are being evaluated for or diagnosed with pancreatic adenocarcinoma (the most common type of pancreatic cancer), to better understand the disease and improve how it is diagnosed and treated. **You may be eligible if:** - You have a mass in your pancreas being investigated by endoscopic ultrasound (with cell sampling) OR - You have a pancreatic mass being evaluated by abdominal CT scan (with or without a biopsy) OR - You have already been diagnosed with pancreatic adenocarcinoma confirmed by tissue or cell analysis **You may NOT be eligible if:** - Your pancreatic tumor turns out to be a different type than adenocarcinoma (e.g., neuroendocrine tumor) - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERcollection of biological samples

Collection of biological samples including whole blood and micro-biopsy from tissue of pancreas


Locations(8)

Béthune hospital center

Béthune, France

Haut-Lévêque Hospital

Bordeaux, France

Huriez Hospital

Lille, France

Jean Mermoz private hosptila

Lyon, France

Saint Eloi Hospital

Montpellier, France

Regional Cancer Center From Montpellier

Montpellier, France

PAU hospital

Pau, France

Rangueil hospital

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06128343


Related Trials